Pennant Group, Inc. (PNTG) stock
PNTGNasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3023% above fair value
$36.50−0.53 (-1.43%)
Close on Nov 17, 2026Market cap $1.27BP/E 40.6Yield –
Pennant EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Pennant's EPS for the twelve months ending Jun 30, 2026 was $0.90, up 15.4% year over year. For fiscal 2025 it was $0.84, up 20.0% from the year before. The highest annual figure on record is $0.84 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.84 | +20.0% |
| FY2024 | Dec 31, 2024 | $0.70 | +59.1% |
| FY2023 | Dec 31, 2023 | $0.44 | +100.0% |
| FY2022 | Dec 31, 2022 | $0.22 | +144.4% |
| FY2021 | Dec 31, 2021 | $0.09 | -82.7% |
| FY2020 | Dec 31, 2020 | $0.52 | +372.7% |
| FY2019 | Dec 31, 2019 | $0.11 | -81.0% |
| FY2018 | Dec 31, 2018 | $0.58 | +61.1% |
| FY2017 | Dec 31, 2017 | $0.36 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.25 | +25.0% |
| Q1 FY2026 | Mar 31, 2026 | $0.24 | +9.1% |
| Q4 FY2025 | Dec 31, 2025 | $0.24 | +50.0% |
| Q3 FY2025 | Sep 30, 2025 | $0.17 | -15.0% |
| Q2 FY2025 | Jun 30, 2025 | $0.20 | +11.1% |
| Q1 FY2025 | Mar 31, 2025 | $0.22 | +37.5% |
| Q4 FY2024 | Dec 31, 2024 | $0.16 | +14.3% |
| Q3 FY2024 | Sep 30, 2024 | $0.20 | +33.3% |
| Q2 FY2024 | Jun 30, 2024 | $0.18 | +100.0% |
| Q1 FY2024 | Mar 31, 2024 | $0.16 | +166.7% |
| Q4 FY2023 | Dec 31, 2023 | $0.14 | +16.7% |
| Q3 FY2023 | Sep 30, 2023 | $0.15 | -6.3% |
| Q2 FY2023 | Jun 30, 2023 | $0.09 | – |
| Q1 FY2023 | Mar 31, 2023 | $0.06 | +100.0% |
| Q4 FY2022 | Dec 31, 2022 | $0.12 | – |
| Q3 FY2022 | Sep 30, 2022 | $0.16 | +300.0% |
| Q2 FY2022 | Jun 30, 2022 | -$0.09 | -200.0% |
| Q1 FY2022 | Mar 31, 2022 | $0.03 | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | -$0.07 | -153.8% |
| Q3 FY2021 | Sep 30, 2021 | $0.04 | -73.3% |
| Q2 FY2021 | Jun 30, 2021 | $0.09 | -40.0% |
| Q1 FY2021 | Mar 31, 2021 | $0.03 | -70.0% |
| Q4 FY2020 | Dec 31, 2020 | $0.13 | – |
| Q3 FY2020 | Sep 30, 2020 | $0.15 | +150.0% |
| Q2 FY2020 | Jun 30, 2020 | $0.15 | +15.4% |
| Q1 FY2020 | Mar 31, 2020 | $0.10 | +100.0% |
| Q4 FY2019 | Dec 31, 2019 | -$0.11 | -178.6% |
| Q3 FY2019 | Sep 30, 2019 | $0.06 | -62.5% |
| Q2 FY2019 | Jun 30, 2019 | $0.13 | – |
| Q1 FY2019 | Mar 31, 2019 | $0.05 | – |
| Q4 FY2018 | Dec 31, 2018 | $0.14 | – |
| Q3 FY2018 | Sep 30, 2018 | $0.16 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?